Peter P. Lee

Billy Wilder Endowed Professor and Chair

Beckman Research Institute, City of Hope

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter P. Lee is the Billy Wilder Endowed Professor and Chair at the Beckman Research Institute, City of Hope, USA. His research primarily focuses on the optimization of cancer therapies, tumor immunology, and the mechanisms of tumor heterogeneity. Recent articles authored by Professor Lee explore topics such as neoadjuvant therapy for colorectal cancer, immune-suppressive mechanisms in metastatic breast cancer, and the role of signaling pathways in cancer immunity.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Daniel Schmolze

Assistant Clinical Professor

City of Hope Comprehensive Cancer Center

UNITED STATES

View details

Jeannine McCune

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Peter Kim

University of Sydney

AUSTRALIA

View details

Jeff Lin

Assistant Clinical Professor

City of Hope

UNITED STATES

View details

Aleksandra Karolak

Assistant Professor

Moffitt Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter P. Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations

Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer—a call for enhanced surveillance strategies

STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer

B cell receptor signaling strength modulates cancer immunity

A minimal model of T cell avidity may identify subtherapeutic vaccine schedules

Concepts and Applications of Information Theory to Immuno-Oncology

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer

Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity

Arhgap25 Deficiency Leads to Decreased Numbers of Peripheral Blood B Cells and Defective Germinal Center Reactions

Selective ablation of cancer cells with low intensity pulsed ultrasound

Collaborators (5)

Daniel Schmolze

Jeannine McCune

Peter Kim

Jeff Lin

Aleksandra Karolak

Make your next move.